Clinical Trials Browser

Phase 3 × Terminated × Triple Negative Breast Neoplasms × Clear all

NCT05134194 2024-04-16

A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer

Phase 3 Terminated

Triple Negative Breast Neoplasms

NCT03055312 2021-01-28

SYSUCC-007

Phase 3 Terminated

Triple Negative Breast Neoplasms